- Protocol Short Name and Number: Allo Transplant in HIV, 0903
- Protocol Long Name: Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodyplastic Syndromes in HIV-infected Patients
- Protocol (PDF)
- Informed Consent and Assent
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0903 Protocol Chair: Joseph Alvarnas, MD
- BMT CTN # 0903 Protocol Co-Chair: Richard Ambinder, MD
- BMT CTN # 0903 Protocol Officer: Willis Navarro
- BMT CTN # 0903 Medical Monitor: Tammy Kindwall-Keller, MD
- BMT CTN # 0903 Protocol Coordinator: bmtctn@emmes.com
- Keywords: HIV, Allogeneic Transplant, Allo Transplant, Allo, Leukemia, Acute Myelogenous Leukemia, AML, Acute Lymphocytic Leukemia, ALL, Myelodysplastic Syndrome, MDS, Lymphoma, HL, NHL, Unrelated, Unrelated Donor, Pediatric, Child, Children, Teen, Adolescent
The BMT CTN 0903 study closed to new patient accrual on December 3, 2015.